Physician profile
Jonathan Clark Wu
NPI 1659347318
$11,327.94
in general payments reported to CMS, 2019-2025
29 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,462 · 2020: $1,569 · 2021: $953 · 2022: $1,172 · 2023: $1,784 · 2024: $1,230 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,883 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,882.64 |
| Travel and Lodging | $289.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,819.18 | 2019-2025 | Grafix, Oasis, Stravix Pl |
| Intuitive Surgical, INC. | $2,081.94 | 2019-2024 | |
| Davol INC. | $1,554.78 | 2019-2025 | Phasix Mesh |
| Boston Scientific Corporation | $748.88 | 2020-2025 | Accolade Sr, S-Icd System Magnet, Resonate El Icd Vr |
| Kerecis Limited | $718.54 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Janssen Pharmaceuticals, INC | $675.66 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $604.42 | 2020-2022 | |
| Osiris Therapeutics INC. | $402.79 | 2019 | |
| Organogenesis INC. | $298.94 | 2019-2024 | Puraply Wound Matrix |
| Baxter Healthcare | $251.88 | 2023-2024 | Tisseel, Perclot |
| Mimedx Group, INC. | $183.01 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $149.21 | 2022-2023 | |
| Abbvie INC. | $124.30 | 2023 | Teflaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.28 | 2024 | Lifevest |
| Cardiovascular Systems INC. | $98.59 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $90.24 | 2025 | Assure Wcd |
| Becton, Dickinson and Company | $87.90 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $68.34 | 2019-2022 | |
| Medtronic, INC. | $61.73 | 2022 | |
| Solventum Corporation | $25.13 | 2025 | Activ.A.C. |
| Misonix INC | $24.74 | 2021 | |
| Tela Bio, INC. | $24.37 | 2024 | Ovitex 2s |
| Paratek Pharmaceuticals, INC. | $19.96 | 2024 | Nuzyra |
| Conmed Corporation | $18.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.00 | 2020 | |
| Kci USA, INC. | $16.48 | 2021 | |
| Integra Lifesciences Corporation | $15.05 | 2022 | |
| Kls-Martin L.P. | $14.85 | 2020 | |
| Melinta Therapeutics, LLC | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.